Our Company

Actelion Pharmaceuticals US, Inc is a subsidiary of Actelion Pharmaceuticals Ltd, a global biopharmaceutical company headquartered in Allschwil/Basel, Switzerland.

Located in South San Francisco, our offices are situated in the hub of California's pharmaceutical and biotech development region. Together with other Actelion subsidiaries in 28 countries around the world, we are focused on the development and commercialization of innovative treatments to serve critical, unmet medical needs.

Actelion People

Throughout its years of rapid growth, Actelion has always been highly conscious of the fact that it is its own people who make the difference.

Learn more about our people

About Us

Actelion was founded on 17 December 1997 and is now a public listed company on the Swiss stock exchange (SIX).

Learn more Facts & Figures

US Corporate Governance

"I firmly believe that corporate responsibility is part of the everyday management of a successful business.”

Jean-Paul Clozel, CEO

Learn more about our commitment

Top of page Print pageSend this page to a friendBookmark with del.icio.usBookmark with diggBookmark with MISTER WONG

Contact

Actelion Pharmaceuticals US, Inc

5000 Shoreline Court, Suite 200

South San Francisco, CA 94080

USA

Phone:+1 650 624 6900

Fax:+1 650 589 1501

Contact us online

Related links

Actelion press releases Our Values Job Opportunities

Downloads

Annual Report Financial performance fact sheet Actelion milestones